MedTrace Logo

Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions

NCT01021267 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-11-26

No results posted yet for this study

Summary

Assessment in an open trial if a standardized saw palmetto preparation has a positive influence on sexual dysfunctions in patients with BPH and sexual dysfunctions.

Conditions

  • Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia

Interventions

DRUG

Saw palmetto berry extract

1x daily 1 capsule containing 320mg lipophilic extract

Sponsors & Collaborators

  • University of London

    collaborator OTHER

  • A. Vogel AG

    lead INDUSTRY

Principal Investigators

  • Eugen Riedi, MD · independent

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01021267 on ClinicalTrials.gov